AbbVie Inc.

ABBV · NYSE
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$0$1$1$4
Dep. & Amort.$2$2$2$2
Deferred Tax$0-$0-$0-$1
Stock-Based Comp.$0$0$0$1
Change in WC$3-$1-$3-$0
Other Non-Cash$1$3$1$1
Operating Cash Flow$7$5$2$7
Investing Activities
PP&E Inv.$1-$0-$0-$0
Net Acquisitions$1-$1-$1-$2
Inv. Purchases-$0-$0-$0-$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$5$0$0$0
Investing Cash Flow-$3-$1-$1-$2
Financing Activities
Debt Repay.-$2$0$3-$4
Stock Issued-$1$0$0$0
Stock Repurch.$0-$0-$1-$0
Dividends Paid-$3-$3-$3-$3
Other Fin. Act.$1$0$0$0
Financing Cash Flow-$5-$3-$1-$7
Forex Effect-$0$0$0-$0
Net Chg. in Cash-$1$1-$0-$2
Supplemental Information
Beg. Cash$6$5$6$7
End Cash$6$6$5$6
Free Cash Flow$8$5$1$7
AbbVie Inc. (ABBV) Financial Statements & Key Stats | AlphaPilot